Not Yet Recruiting
Adebrelimab Plus Full-course Neoadjuvant Therapy for Resectable Locally Advanced ESCC (Phase 2)
NCT07584031
- Conditions
- ESCC
- Locations
-
Not specified
Clinical trial condition
Explore clinical trials studying ESCC. Study availability and eligibility vary by location and protocol.
NCT07584031
Not specified
NCT07533305
Not specified
NCT07531979
NCT07524374
NCT07493993
NCT07388095
Not specified
NCT07196345
NCT06531291
NCT07488624
NCT07015489